Abraham Todd 4/A
4/A · ENDOLOGIX INC /DE/ · Filed Oct 2, 2012
Insider Transaction Report
Form 4/AAmended
Abraham Todd
VP of Operations
Transactions
- Award
Common Stock
2012-09-09$12.62/sh+28,944$365,273→ 59,138 total
Footnotes (5)
- [F1]25% vesting to occur upon the achievement of Nellix device revenue target for a month.
- [F2]25% vesting to occur upon U.S. regulatory approval of Nellix device.
- [F3]25% vesting to occur upon U.S. regulatory approval of Ventana device.
- [F4]25% vesting to occur upon U.S.regulatory approval of a second-generation AFX device.
- [F5]100% cliff vesting to occur 9/9/2016 in the event milestones are not achieved.